Motor Neurone Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with sporadic ALS (the non-inherited form) that has been confirmed as "definite" or "clinically probable" according to recognised international diagnostic guidelines
- People whose lung breathing capacity is at least 50% of the expected level for their age and size, and who have a detectable response in a specific brain-to-muscle electrical signal test
- People aged between 21 and 80 years old, of any gender
Who may not be able to join:
- People who have the inherited (family) form of ALS based on their medical history
- People who are unable to tolerate, or have a medical reason to avoid, the brain stimulation test (TMS) or MRI scan used in this trial (confirm with trial site for the full list of specific contraindications)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +34932 48 30 00
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in the short intracortical inhibition (SICI) of the motor cortex from baseline to week 8.; Change from baseline to month 6 in the ALS functional rating scale-revised (ALSFRS-R) total score
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.